wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q35229741-246AF4B4-4CBD-4ECC-B89A-CFF32645381A
Q35229741-246AF4B4-4CBD-4ECC-B89A-CFF32645381A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35229741-246AF4B4-4CBD-4ECC-B89A-CFF32645381A
A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer
P2860
Q35229741-246AF4B4-4CBD-4ECC-B89A-CFF32645381A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35229741-246AF4B4-4CBD-4ECC-B89A-CFF32645381A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4dff5cf855bfd73751570e96dc70904b845f42cc
P2860
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial